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Analysis at the Sequence Level of
Mutations Induced by the Ultimate
Carcinogen N Acetoxy NM2
Acetylaminof uorene
by Robert P. P. Fuchs,* Nicole Schwartz*
and Michel P. Daune*
The covalent binding of an ultimate carcinogen to the DNA bases or phosphate groups creates a
premutational lesion that in vivo is processed by the repair, replication and recombination enzymes,
and eventually may be converted into a mutation. Being interested in the way that an initial premu-
tational event is converted into a stable heritable mutation, we have sequenced stable mutations in
a gene that has formed covalent adducts in vitro with N-acetoxy-N-2-acetylaminofluorene (N-AcO-
AAF, a model for the ultimate metabolite of the rat liver carcinogen 2-acetylaminofluorene, AAF).
In vivo studies have shown the mutagenicity of AAF and its derivatives in both bacterial and euka-
ryotic systems. N-AcO-AAF reacts in vitro with DNA leading mainly to the formation of a guanine
adduct, N-24deoxyguanosin-8-yl)acetylaminofluorene (80%) and to at least three minor adducts.
Studies by our group showed that binding ofN-AcO-AAF to DNA resulted in a local distortion of the
DNA helix around the C-8 adduct (the insertion-denaturation model).
We describe here the analysis of forward mutations induced in the tetracycline-resistance gene of
pBR322 by directing the chemical reaction of the carcinogen to a small restriction fragment
(BamHI-Sall) inside the antibiotic-resistance gene. Mutants are selected for ampicillin (Ap) resis-
tance and tetracycline (Tc) sensitivity. The plasmid DNA of such mutants was analyzed for sequence
changes in the fragment where the AAF binding had been directed.
We show here that the mutations are mainly frameshifts involving GC base pairs and that certain
base pairs (hotspots) are affected at high frequencies.
Introduction
An important step in the carcinogenic process is
thought to be the initial attack of the DNA molecule
by a so-called ultimate carcinogen. In fact, more
than 90% of the carcinogens tested are mutagens in
bacterial systems (1). The premutational event is
the covalent binding of the ultimate carcinogen to
the DNA bases or phosphate groups. The chemical
structure of the adducts formed, and to a lesser
extent the structural changes induced in the DNA
double helix in the neighborhood of the adducts, has
been extensively studied during the last ten years.
However the crucial question is "How will the dif-
ferent repair, replication and recombination en-
zymes handle these chemically modified bases?" In
other words, since the end point of this initial step
is a mutation, "How is this initial premutational
event converted into a stable and heritable
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mutation?" N-Acetoxy-N-2-acetylaminofluorene (N-
AcO-AAF) is a model ultimate metabolite of the
strong rat liver carcinogen 2-acetylaminofluorene
(AAF). In vivo studies have shown the mutagenicity
of AAF and its derivatives in both bacterial (2, 3)
and eukaryotic systems (4). N-AcO-AAF reacts in
vitro with DNA leading mainly to the formation of a
guanine adduct (5), N-24deoxyguanosin-8-yl)acetyl-
aminofluorene (80%) and also to at least three
minor adducts (N. Schwartz, R. P. P. Fuchs and M.
P. Daune, unpublished results), one of which is char-
acterized as 34deoxyguanosin-N2-yl)acetylaminofluo-
rene (6).
Studies from our group led to the general conclu-
sion that binding ofN-AcO-AAF to DNA resulted in
a local distortion of the DNA helix around the C-8
adduct (7-9). We have called this structural
alteration the insertion-denaturation model (10). A
similar model has been proposed by other in-
vestigators (11).
In this paper we describe the analysis of forward
mutations induced in the tetracycline-resistanceFUCHS, SCHWARTZ AND DA UNE
gene of pBR322 by directing the chemical reaction
of the carcinogen to a small restriction fragment
(BamHI, Sail) inside the antibiotic-resistance gene.
A preliminary report of this work has recently been
published (12).
Material and Methods
The E. coli strains used were AB 1157 or AB
1886 (13). N-AcO-AAF (3H-ring) was synthetized as
described previously (14) (specific activity: 196
mC/mmole). N-AcO-AAF (3H-ring) reaction with su-
percoiled plasmid DNA was performed in lOmM
Tris, lmM EDTA, pH 8, buffer (TE buffer) con-
taining 5% of ethanol (DNA concentration: 50
,ug/mL). Removal of unbound fluorene derivatives
was achieved by four successive ethanol precipita-
tions. The number of AAF residues bound per plas-
mid molecule was determined as previously de-
scribed.
Samples of pBR322 reacted with N-AcO-AAF to
various extends (ranging from 0 to 2.5% of modified
bases) were digested with BamHI, and SalI
restriction enzymes (Boehringer, Mannheim). The
large fragment (16S fragment) and the small
fragment (6S fragment) were separated and purified
either by velocity sedimentation on sucrose
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FIGURE 1. Strategy for the site-directed mutagenesis
experiment.
gradients (5% to 20%) or by electrophoresis on
0.8% agarose or on 8% polyacrylamide gels followed
by electroelution. T4 DNA ligase (Biolabs) was used
to ligate the unmodified 16S fragment with either
the unmodified 6S fragment of the 6S fragments ob-
tained from the various AAF-modified pBR322 sam-
ples (6S-AAF). The ligation was performed under the
conditions specified by the T4 DNA ligase manufac-
turer. The DNA fragment concentrations were 16.5
,g/mL for the 16S fragment and 7.5pg/mL for the 6S
fragment.
Ultraviolet Irradiation of the Cells
prior to Transformation
In some cases, the E. coli cells were ultraviolet-
irradiated prior to the transformation procedure.
This treatment was used to induce the cellular SOS
response. The cells were ultraviolet-irradiated as a
suspension in 0.O1M MgSO4 with a germicidal lamp
(15 W, Phillips) at a dose giving about 50% survival
(i.e., 60 J/m2 for the wild type strain, AB 1157; 6
J/m2 for the uvrA strain, AB 1886). The cells were
then incubated in LB medium for 30 min at 370C to
allow expression of the SOS function.
E. coli Transformation and Selection of
the Ampicillin-Resistant (ApR)and
Tetracycline-Sensitive (TcS) Clones
The E. coli was made competent for transforma-
tion by the classical CaCl2 treatment procedure (16).
The different ligation mixtures were diluted by a
factor of 100 in lOmM Tris, lOmM CaCl2 and 10mM
MgCl2 (pH 7) and used to transform the competent
cell suspension by mixing one volume of the DNA
solution with two volumes of the concentrated E.
coli suspension. Following the transformation
procedure, the cells were spread on LB plates
containing Ampicillin (50 jAg/mL) and incubated at
370C overnight. The clones were then replated on
LB plates containing tetracycline (20 ,ug/mL). Clones
which grew on Ap but not on Tc were scored as
ApR, Tcs mutants. Such individual mutant clones
were then grown further in LB medium plus Ampi-
cillin for preparation of the plasmid DNA contained
in these clones. Plasmid DNA was purified either on
a small scale (10 mL of culture) by an adaptation of
the method of Clewell and Helinski (17) or on a
larger scale (11 culture) by a NaCl/SDS lysis
procedure followed by a CsCl/Ethidium bromide
centrifugation step (18).
DNA Sequence Analysis of the Mutants
Plasmids were digested with BamHI and SalI re-
striction enzymes and IP end-labeled at their 5'
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extremities with T4 DNA kinase (Boehringer,
Mannheim). Strand separation and sequencing were
performed according to the method of Maxam and
Gilbert (19).
Results
The strategy that was used to obtain mutants in
the tetracycline resistance gene, within the small
restriction fragment (BamHI, Sal), is outlined in
Figure 1. This restriction fragment (275 base pairs
long: 6S fragment) modified to various extents with
N-AcO-AAF[3H-ring] was reinserted by in vitro
ligation into the nonreacted large (BamHI, Sail)
restriction fragment (16S fragment). This large
fragment contains both the gene coding for the 13-
lactamase (Ap resistance gene) and the origin of
replication. The ligation mixture was used to
transform CaCl2-treated E. coli recipient cells.
Mutants are selected for Ampicillin (Ap) resistance
and tetracycline (Tc) sensitivity.
Frequency of Obtention and Restriction
Enzyme Analysis of the ApR TcS Mutants
Mutation frequencies were calculated as the ratio
of ApR TcS clones/ApR clones. The mutation
frequency in the control experiment in which the
16S fragment was ligated to a nonmodified 6S
fragment was 0.4% when no ultraviolet treatment
was applied to the bacteria prior to the tran-
sformation step. This frequency was similar (0.6%)
when the ultraviolet treatment was applied. When
analyzed by gel electrophoresis, the plasmid DNAs
isolated from such clones were always shorter in
length than the original pBR322. In general, the size
reduction ranged from 0.2 to 0.8 kb. The restriction
analysis pattern showed that these mutant DNAs
had retained the unique Eco RI site but that in
general they had lost both the BamHI SalI
restriction sites. We call these mutants class I
mutants and suggest that they mainly arise from
the dimerization of the 16S fragment. Such dimers,
which have the ApR TcS phenotype, are then
converted to smaller plasmids (monomers) through
in vivo recombination. Work is in progress to lower
this mutation background by using an alkaline
phosphatase-treated 16S fragment. Class I mutants
were easily recognized and excluded from the pool
of mutants to be sequenced.
When 6S-AAF fragments ligated to the nonmodi-
fied 16S fragment are used to transform E. coli one
finds a decrease in the transformation efficiency
with increasing levels of bound AAF residues. (Fig.
2). The extent of this AAF-dependent inactivation of
transformation is strongly related to the general
repair genotype of the recipient cell (R. P. P. Fuchs
and E. Seeberg, manuscript in preparation). One
also finds a corresponding increase in the mutation
frequency, provided the cells are exposed to UV
prior to the transformation step. The mutant DNAs
isolated from such experiments fall into two classes
when analyzed by gel electrophoresis: class I
mutants defined as in the control experiment, and
class II mutants, exhibiting the original size of
pBR322 and retaining both BamHI and SalI
restriction sites.
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FIGURE 2. Relative transformation efficiency and mutation
frequencies as a function of the number of AAF residues
bound to the 6S fragment: (U) relative transformation
efficiency (log scale); (A) class I mutants; (0) class II mu-
tants. The transformation of E. coli AB 1157 strain has
been performed after ultraviolet irradiation of the cells (60
J/m2) as described in the legend to Figure 1. Selection of
the transformants was done on LB plates containing ampi-
cillin (50 jAg/mL). Mutants were selected by replica plating
on LB plates containing tetracycline (20 Ag/mL).
The frequency of class II mutants increases with
the level of AAF modification and reaches about
3% at the highest level tested (Fig. 2). It should be
stressed that only the class II mutation frequency is
a function of -AAF modification and dependent on
ultraviolet irradiation of the host cell (for the
conditions, see legend to Fig. 1).
Sequence Analysis of Nine pBR322 ApR
TcS Mutants
Nine class II mutant plasmids were isolated from
either the wild type E. coli strain, AB 1157, or the
corresponding uvrA mutant strain, AB 1886. The
double BamHI/SalI digested DNA was -P-end-
labeled at the 5' extremities and sequenced ac-
cording to the Maxam and Gilbert technique (19).
The sequence of the wild type 6S fragment of
pBR322 was found to be identical to the sequence
published by Sutcliffe (20). In all of the nine class II
mutants we found a mutation located within the 6S
fragment. All of the mutants showed a deletion of
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either a single GC base pair or a doublet of adjacent
GC-CG base pairs. Two of these mutants (numbers
35 and 36) also had a second mutation (Table 1).
Two hot spot sequences for mutagenesis were
found within the collection of the nine mutants.
Hot SpotSequence 1. AS shown in Table 1, four
out of the nine mutants (mutants number 4, 30, 41
and 45) show a deletion of a single G residue at
position 520 or 521. (Numbering starts clockwise
from the unique EcoRIsite). It should be noted that
the four mutants have arisen under quite different
conditions (i.e., in two different strains, with or
without ultraviolet induction of the SOS functions,
with very different AAF modification levels).
Hot Spot Sequence 2. Mutants 34, as shown in
Figure 3, and 36 exhibit a -2 deletion within the al-
ternating GCGC sequence at positions 435-438 (de-
letion of a GC sequence at position 435-436 or 437-
438, or of a CG sequence at position 436-437). Mu-
tant 33 also exhibits a -2 deletion within a GCGC
sequence at position 548-551. The mutation in
mutant 35, although being different (-1 deletion of G
416 and double transition at 414-415) also takes
place within the same 6-nucleotide long sequence,
GGCGCC, sequence that is in common to all four
mutants 34, 36, 33, 35. This given sequence, that is
found three times within the 6S fragment, can
therefore be considered as a mutational hot spot.
Such a GC deletion in an alternating GC sequence
was shown in vivo to be a hot spot for reversion of
the mutation, his D 3052, in Salmonellk by the
mutagen 2-nitrosofluorene (21). It is striking to find
that the same type of mutation occurs in both a
reversion and a forward mutation assay.
Conclusion
The reason why such particular sequences are
hot spots for mutagenesis is not clear. Whether or
not such sequences are hot spots for the AAF bind-
ing reaction itself is presently under investigation.
Alternatively, it is more likely that the processing
of the premutational lesions is strongly sequence-
dependent. It is noteworthy that at both hot spots
the sequence is such that one can draw a short
"hairpin-type" secondary structure (Fig. 4). Such
hairpins are too short to be stable by itself but
might be highly stabilized by the conformational
change that -AAF introduces when bound to C-8 of
guanine. As stated by the insertion-denaturation
model proposed by Fuchs and co-workers (7, 10),
there is a local denaturation of the helix around the
Description of
the mutation
- 1 deletion of
G 520 or 521
Mutant
number
4
30
41
45
Strain
AB 1886
AB 1886
AB 1157
AB 1157
Induction of
SOS functions
Table 1
Average number of
bound AAF residues/6S
fragment
2.0
2.8
13.8
2.8
Sequence in the neighborhood of the mutationa
511 520 529
G G G T A T G G T G:GlC A G G C C C G
- 1
- 1 deletion of
G 389 or 390
- 2 deletion of
GC 435-436 or
437-438 or CG
436-437
Addition of a
C within se-
quence with
526-528
- 2 deletion of
GC 548-549 or
550-551 or CG
549-550
- 1 deletion of
of G 416 and
double transi-
tion at 414-415
+
+
+
+
381
32 AB 1157
34 AB 1157
36 AB 1157
36
8.8
6.6
8.8
390 399
T C T A C G C C,G,G:A C G C A T C G T
- 1
428 446
GTTGCTG:G,CiGiC'C TATATCG
-2
518 + 1 [ 536
GTGGCAGGCCCGTGGCCGG
33 AB 1157
35 AB 1157
13.8
8.8
540 558
AiG CTT C,C A T C T C C
-2
406 424
CATCACCGFG7CGIC CCACAGGT
double t -1
transition AT
'The sequences appearing in this table are the wild type sequences with the numbering defined by Sutcliffe (20). The bases in-
volved in the deletion mutations are boxed with dotted lines. The different possibilities to obtain a given mutated sequence are
shown. Mutant 36 exhibits two mutations: a - 2 deletion as in mutant 34 and a + 1 addition of a C residue within the sequence CCC
at positions 526-528. Mutant 35 has got a - 1 deletion of a G at position 416 and a double transition, GC - AT, at position 414-415.
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FIGURE 3. Part of the sequence of mutant 34 and of the wild type DNA showing the - 2 deletion of a CG doublet within the hot
spot sequence GGCGCC.
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guanine-AAF adduct that might favor the hairpin
structure shown in Figure 4. Due to the multicopy
state and to the recessivity of the mutations that
are scored in our system, the conversion of the
premutagenic lesion into a stable mutation most
likely occurs simultaneously in both strands prior to
replication.
G sdGMP-C8-AAF
GC
5'ATGGTG4CAGGCC3_ 5'ATGG GGCC3
TACCACCGTCCGG TACC CCGG
A T
CG
Hot spot sequence 1 (mutants 4,30,41,45)
d* dGMP-CS-AAF CG
GC
5'WXGGCGCCY Z- 5__WX __ Z5 ~WXCCGCGGYZ2L -WX' Y'Z'-
C G
CG
GC
Hot spot sequence 2 (mutants 34,36.33, 35)
FIGURE 4. Hypothetical hairpin structure at hot spot
sequences 1 and 2. According to the insertion-denaturation
model proposed by Fuchs and co-workers (7, 10), there is a
local denaturation of the helix around the guanine-AAF
adduct that might favor the hairpin structure.
The molecular mechanism by which the mutation
is being fixed remains to be elucidated.
This work has been supported by Grant No. 79.7.0664 from
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